About iSpecimen
iSpecimen is a company based in Lexington (United States) founded in 2009. iSpecimen has raised $11.86 million across 8 funding rounds. The company has 24 employees as of December 31, 2024. iSpecimen offers products and services including iSpecimen Marketplace, Biofluids Inventory, and Tissue Samples. iSpecimen operates in a competitive market with competitors including GenVault Corporation, PrecisionMed, Cryoniss, AminoChain and ViaCell, among others.
- Headquarter Lexington, United States
- Employees 24 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$9.29 M (USD)-6.42as on Dec 31, 2024
-
Net Profit
-$12.5 M (USD)-12.6as on Dec 31, 2024
-
EBITDA
-$10.11 M (USD)-11.01as on Dec 31, 2024
-
Total Equity Funding
$11.86 M (USD)
in 8 rounds
-
Latest Funding Round
$5.5 M (USD), Post-IPO
Dec 30, 2025
-
Investors
-
Employee Count
24
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of iSpecimen
iSpecimen is a publicly listed company on the NASDAQ with ticker symbol ISPC in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of iSpecimen
iSpecimen offers a comprehensive portfolio of products and services, including iSpecimen Marketplace, Biofluids Inventory, and Tissue Samples.
Online system for accessing and ordering human biospecimens for research.
Collection of biofluids like blood and urine for life science studies.
Provision of fresh, frozen, and processed tissues for medical research.
People of iSpecimen
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of iSpecimen
iSpecimen has successfully raised a total of $11.86M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5.5 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $5.5M
-
First Round
First Round
(12 Jul 2012)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Post-IPO - iSpecimen | Valuation |
investors |
|
| Aug, 2025 | Amount | Post-IPO - iSpecimen | Valuation |
investors |
|
| Aug, 2025 | Amount | Post-IPO - iSpecimen | Valuation |
investors |
|
Investments & Acquisitions by iSpecimen
Financial Statements - iSpecimen
Ispecimen Comparisons
Competitors of iSpecimen
iSpecimen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, PrecisionMed, Cryoniss, AminoChain and ViaCell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| domain | founded_year | HQ Location |
Human biological materials for research are supplied via a biorepository.
|
|
| domain | founded_year | HQ Location |
Provider of biobanking services for life sciences industries
|
|
| domain | founded_year | HQ Location |
A blockchain-based platform for tokenizing and incentivizing stem cell donations
|
|
| domain | founded_year | HQ Location |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
Frequently Asked Questions about iSpecimen
iSpecimen was founded in 2009 and raised its 1st funding round 3 years after it was founded.
iSpecimen is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
iSpecimen is a funded company, having raised a total of $11.86M across 8 funding rounds to date. The company's 1st funding round was a Post-IPO of $1.75M, raised on Jul 12, 2012.
As of Dec 31, 2024, the latest employee count at iSpecimen is 24.
Annual revenue of iSpecimen is $9.29M as on Dec 31, 2024.
iSpecimen was founded in 2009 and is based in Lexington, United States. Human clinical specimens are provided by the company to therapeutic, diagnostic, and academic research sectors through an online platform. Liquid and solid samples, such as plasma, serum, whole blood, urine, cerebrospinal fluid, and FFPE blocks or slides, are made available. Contract research organizations, government agencies, and academic institutions are included among the customers served.
iSpecimen's top competitors include AminoChain, GenVault Corporation and Cryoniss.
iSpecimen offers iSpecimen Marketplace, Biofluids Inventory, and Tissue Samples.
Yes, iSpecimen is publicly traded on NASDAQ under the ticker symbol ISPC.
The ticker symbol of iSpecimen is ISPC on NASDAQ.